Feil Family Brain & Mind Research Institute
Found 438 results
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is P  [Clear All Filters]
2019
Fitzgerald ML, Mackie K, Pickel VM.  2019.  Ultrastructural localization of cannabinoid-1 (CB1) and mGluR5 receptors in the prefrontal cortex and amygdala.. J Comp Neurol.
Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA, Dichgans M.  2019.  Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel.. J Am Coll Cardiol. 73(25):3326-3344.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ et al..  2019.  Vascular dysfunction-The disregarded partner of Alzheimer's disease.. Alzheimers Dement. 15(1):158-167.
2018
Ranea-Robles P, Launay N, Ruiz M, Calingasan NYlagan, Dumont M, Naudí A, Portero-Otín M, Pamplona R, Ferrer I, M Beal F et al..  2018.  Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.. EMBO Mol Med.
Ranea-Robles P, Launay N, Ruiz M, Calingasan NYlagan, Dumont M, Naudí A, Portero-Otín M, Pamplona R, Ferrer I, M Beal F et al..  2018.  Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.. EMBO Mol Med.
Ranea-Robles P, Launay N, Ruiz M, Calingasan NYlagan, Dumont M, Naudí A, Portero-Otín M, Pamplona R, Ferrer I, M Beal F et al..  2018.  Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy.. EMBO Mol Med.
Brea D, Poon C, Murphy M, Lubitz G, Iadecola C, Anrather J.  2018.  Ablation of nasal-associated lymphoid tissue does not affect focal ischemic brain injury in mice.. PLoS One. 13(10):e0205470.
Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N et al..  2018.  Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.. Nature.
Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N et al..  2018.  Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.. Nature.
Intlekofer AM, Shih AH, Wang B, Nazir A, Rustenburg AS, Albanese SK, Patel M, Famulare C, Correa FM, Takemoto N et al..  2018.  Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations.. Nature.
Gaisina IN, Lee SH, Kaidery NA, Ben Aissa M, Ahuja M, Smirnova NN, Wakade S, Gaisin A, Bourassa MW, Ratan RR et al..  2018.  Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors.. ACS Chem Neurosci.
Koizumi K, Hattori Y, Ahn SJi, Buendia I, Ciacciarelli A, Uekawa K, Wang G, Hiller A, Zhao L, Voss HU et al..  2018.  Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function.. Nat Commun. 9(1):3816.
Koizumi K, Hattori Y, Ahn SJi, Buendia I, Ciacciarelli A, Uekawa K, Wang G, Hiller A, Zhao L, Voss HU et al..  2018.  Apoε4 disrupts neurovascular regulation and undermines white matter integrity and cognitive function.. Nat Commun. 9(1):3816.
Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Tagawa ST, Panageas KS, DeAngelis LM.  2018.  Arterial thromboembolic events preceding the diagnosis of cancer in older persons.. Blood.
Chen MLin, Gupta A, Chatterjee A, Khazanova D, Dou E, Patel H, Gialdini G, Merkler AE, Navi BB, Kamel H.  2018.  Association Between Unruptured Intracranial Aneurysms and Downstream Stroke.. Stroke. 49(9):2029-2033.
Kamel H, Longstreth WT, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, Meinzer C, Dillon C, Ewing I, Spilker JA et al..  2018.  The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods.. Int J Stroke. :1747493018799981.
Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, Stein PK, deFilippi CR, Gottesman RF, Heckbert SR et al..  2018.  Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).. Stroke.
Kummer BR, Lerario MP, Navi BB, Ganzman AC, Ribaudo D, Mir SA, Pishanidar S, Lekic T, Williams O, Kamel H et al..  2018.  Clinical Information Systems Integration in New York City's First Mobile Stroke Unit.. Appl Clin Inform. 9(1):89-98.
Gan L, Cookson MR, Petrucelli L, La Spada AR.  2018.  Converging pathways in neurodegeneration, from genetics to mechanisms.. Nat Neurosci. 21(10):1300-1309.
Brady E, Parikh NS, Navi BB, Gupta A, Schweitzer AD.  2018.  The imaging spectrum of posterior reversible encephalopathy syndrome: A pictorial review.. Clin Imaging. 47:80-89.
Ranganathan U, Kaunzner U, Foster S, Vartanian T, Perumal JS.  2018.  Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis.. Mult Scler. 24(4):540-542.
Kocsik AS, Klein DE, Liedke M, Kaunzner UW, Nealon NM, Gauthier SA, Vartanian T, Perumal JS.  2018.  Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS.. J Neurol. 265(5):1226-1229.
Yang J, Park KWoo, Cho S.  2018.  Inhibition of CD36 reduces visceral fat accumulation and improves insulin resistance in diet-induced obese BDNF mice.. J Biol Chem.